Rui Cai, Ph.D.

Rui has over 10 years of experience providing advice on health economic modelling and market access to clients in the life sciences and medical device industry. Prior to joining Parexel in March 2023, she worked in academia, pharma and global pharma consulting companies. 

Rui has extensive experience in leading cost-effectiveness and budget impact modelling projects, at global and regional levels, as well as leading evidence synthesis, delphi panels, and dossier and value communication preparations. 
Rui also has experience in conducting indication-specific HTA landscape assessments, leading real-world evidence (RWE) studies and supporting HTA submissions in regions such Europe, China and US.

Education
Rui holds a PhD in Epidemiology (Infectious Disease Control), Erasmus Medical Center Rotterdam, the Netherlands. She is bachelor graduate in Medicine from Peking University in China.